SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001140361-23-014261
Filing Date
2023-03-28
Accepted
2023-03-28 16:24:47
Documents
5

Document Format Files

Seq Description Document Type Size
1 425 brhc10050462_425.htm 425 36644
2 EXHIBIT 99.1 brhc10050462_ex99-1.htm EX-99.1 99998
3 image00001.jpg GRAPHIC 3087
4 image00002.jpg GRAPHIC 1440
5 image00004.jpg GRAPHIC 1700
  Complete submission text file 0001140361-23-014261.txt   147631
Mailing Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138
Business Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138 6174531000
INFINITY PHARMACEUTICALS, INC. (Filed by) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138
Business Address 1100 MASSACHUSETTS AVENUE FLOOR 4 CAMBRIDGE MA 02138 6174531000
INFINITY PHARMACEUTICALS, INC. (Subject) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 000-31141 | Film No.: 23769926
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences